GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IntriCon Corp (NAS:IIN) » Definitions » Capex-to-Operating-Cash-Flow

IntriCon (IntriCon) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2022)


View and export this data going back to 1968. Start your Free Trial

What is IntriCon Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

IntriCon's Capital Expenditure for the three months ended in Mar. 2022 was $-2.13 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2022 was $-1.66 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


IntriCon Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for IntriCon's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntriCon Capex-to-Operating-Cash-Flow Chart

IntriCon Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.54 31.09 3.68 0.65 6.22

IntriCon Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 - 0.37 - -

Competitive Comparison of IntriCon's Capex-to-Operating-Cash-Flow

For the Medical Instruments & Supplies subindustry, IntriCon's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IntriCon's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IntriCon's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IntriCon's Capex-to-Operating-Cash-Flow falls into.



IntriCon Capex-to-Operating-Cash-Flow Calculation

IntriCon's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2021 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-2.725) / 0.438
=6.22

IntriCon's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2022 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-2.125) / -1.658
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IntriCon  (NAS:IIN) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


IntriCon Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IntriCon's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


IntriCon (IntriCon) Business Description

Traded in Other Exchanges
N/A
Address
1260 Red Fox Road, Arden Hills, MN, USA, 55112
IntriCon Corp is an international company and joint development manufacturer (JDM) of micromedical components, sub-assemblies and final devices. The company serves as a JDM partner to medical device original equipment manufacturers by designing, developing, engineering, manufacturing, packaging and distributing micromedical products for high growth markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. It manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and complete body-worn devices for leading and emerging medical device manufacturers.
Executives
Annalee Lutgen officer: Interim CFO C/O INTRICON CORPORATION 1260 RED FOX ROAD ARDEN HILLS MN 55112
Michael Geraci officer: Vice President, Sales 1260 RED FOX ROAD ARDEN HILLS MN 55112
Dennis Gonsior officer: Vice Pres., Global Operations 1260 RED FOX ROAD ARDEN HILLS MN 55112
Kathleen P. Pepski director 3100 EAST HENNEPIN AVENUE, MINNEAPOLIS MN 55413
Ellen Scipta officer: CFO C/O INTRICON CORPORATION, 1260 RED FOX ROAD, ARDEN HILLS MN 55112
Heather D. Rider director C/O INOGEN, INC., 326 BOLLAY DRIVE, GOLETA CA 93117
Raymond Huggenberger director 326 BOLLAY DRIVE, GOLETA CA 93117
Greg Gruenhagen officer: VP, Corp. Qlty. & Reg. Affairs C/O INTRICON CORPORATION 1260 RED FOX ROAD ARDEN HILLS MN 55112
Philip Irving Smith director 4503 BROWNDALE AVENUE, EDINA MN 55424
Scott Longval officer: Chief Financial Officer 1260 RED FOX ROAD ARDEN HILLS MN 55112
Mark Stephen Gorder director, officer: President & CEO 1260 RED FOX RD ARDEN HILLS MN 55112
Steven Binnix officer: Vice President-RTI Electronics 1260 RED FOX ROAD ARDEN HILLS MN 55112
Michael J Mckenna director 8650 S OCEAN DRIVE APT 701 JENSEN BEACH FL 34957
Robert N Masucci director 1406 GRASSHOPPER LANE GWYNEDD VALLEY PA 19437
Philip N Seamon director 1260 RED FOX ROAD ARDEN HILLS MN 55112